These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26490613)

  • 1. Immunology: Chronic effects of acute infections.
    Harris N
    Nature; 2015 Oct; 526(7574):509-10. PubMed ID: 26490613
    [No Abstract]   [Full Text] [Related]  

  • 2. IMMUNOLOGY. From transient infection to chronic disease.
    Nathan C
    Science; 2015 Oct; 350(6257):161. PubMed ID: 26450196
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosal immunology: Battle scars.
    Bordon Y
    Nat Rev Immunol; 2015 Nov; 15(11):668. PubMed ID: 26494049
    [No Abstract]   [Full Text] [Related]  

  • 4. Winning the Microbial Battle, but Not the War.
    Chu H; Mazmanian SK
    Cell; 2015 Oct; 163(2):271-2. PubMed ID: 26451475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Infectious Cause of the Chronic Effect.
    Hill AA; Diehl GE
    Cell Host Microbe; 2015 Oct; 18(4):383-5. PubMed ID: 26468738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota-Dependent Sequelae of Acute Infection Compromise Tissue-Specific Immunity.
    Fonseca DM; Hand TW; Han SJ; Gerner MY; Glatman Zaretsky A; Byrd AL; Harrison OJ; Ortiz AM; Quinones M; Trinchieri G; Brenchley JM; Brodsky IE; Germain RN; Randolph GJ; Belkaid Y
    Cell; 2015 Oct; 163(2):354-66. PubMed ID: 26451485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
    Fisher ML; Castillo C; Mecsas J
    Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Yersinia pseudotuberculosis-derived mitogen (YPM) on the murine immune system.
    Carnoy C; Loiez C; Faveeuw C; Grangette C; Desreumaux P; Simonet M
    Adv Exp Med Biol; 2003; 529():133-5. PubMed ID: 12756744
    [No Abstract]   [Full Text] [Related]  

  • 9. Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling.
    Pasztoi M; Bonifacius A; Pezoldt J; Kulkarni D; Niemz J; Yang J; Teich R; Hajek J; Pisano F; Rohde M; Dersch P; Huehn J
    Cell Mol Life Sci; 2017 Aug; 74(15):2839-2850. PubMed ID: 28378044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic role of a superantigen in Yersinia pseudotuberculosis infection.
    Abe J; Kano H; Nogami H; Matsumoto S; Baba K; Saito H; Kohsaka T
    Adv Exp Med Biol; 2003; 529():459-61. PubMed ID: 12756809
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response to diphtheria toxin-mediated depletion complicates the use of the CD11c-DTR(tg) model for studies of bacterial gastrointestinal infections.
    Westermark L; Fahlgren A; Fällman M
    Microb Pathog; 2012 Sep; 53(3-4):154-61. PubMed ID: 22771374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
    Fahlgren A; Westermark L; Akopyan K; Fällman M
    Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A recent case of ileomesenteric adenopathy due to Pasteurella pseudotuberculosis].
    BERTHON ; MOLLARET H
    Mem Acad Chir (Paris); 1960 Feb 17-24; 86():173-4. PubMed ID: 13849037
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prophylaxis of the experimental pseudotuberculosis infection by immunization with porin from Yersinia pseudotuberculosis].
    Darmov IV; Marakulin IV; Pogorel'skiĭ IP; Novikova OD; Portniagina OIu; Solov'eva TF
    Biull Eksp Biol Med; 1999 Feb; 127(2):221-3. PubMed ID: 10095962
    [No Abstract]   [Full Text] [Related]  

  • 15. An extended antigenic scheme for Yersinia pseudotuberculosis.
    Aleksić S; Suchan G; Bockemühl J; Aleksić V
    Contrib Microbiol Immunol; 1991; 12():235-8. PubMed ID: 1718658
    [No Abstract]   [Full Text] [Related]  

  • 16. Trypsin-like proteinase and its endogenous inhibitor from Yersinia pseudotuberculosis. Biological activity.
    Burtseva TI; Loenko YN
    Biochemistry (Mosc); 1999 Sep; 64(9):986-9. PubMed ID: 10521713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of infections with wild and mutant Yersinia pseudotuberculosis strains in rabbit oral model.
    Najdenski H; Vesselinova A; Golkocheva E; Garbom S; Wolf-Watz H
    Adv Exp Med Biol; 2003; 529():117-20. PubMed ID: 12756740
    [No Abstract]   [Full Text] [Related]  

  • 18. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Chart H; Cheasty T
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yersinia pseudotuberculosis adhesins regulate tissue-specific colonization and immune cell localization in a mouse model of systemic infection.
    Hudson KJ; Bouton AH
    Infect Immun; 2006 Nov; 74(11):6487-90. PubMed ID: 16920785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Yersinia specific antibodies in hospitalized patients with arthritis and Reiter syndrome.
    Constantiniu S; Chiriac R; Popovici N
    Arch Roum Pathol Exp Microbiol; 1989; 48(4):341-6. PubMed ID: 2520672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.